Raymond James analyst Melissa Fairbanks raised the firm’s price target on Microchip (MCHP) to $65 from $60 and keeps a Strong Buy rating on the shares. The company continues to make significant progress toward returning to more normalized business trends, and management believes Microchip has “turned the corner” toward a cyclical recovery, bringing with it a return to revenue growth and margin expansion, the analyst tells investors in a research note. Microchip is an analog player with meaningful upside potential as business conditions improve, the firm argues.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MCHP:
- Trump administration to rescind chip curbs, Bloomberg reports
- Microchip upgraded to Neutral at BofA on sales inflection, cost cuts
- Microchip upgraded to Neutral from Underperform at BofA
- Positive Outlook for Microchip: Strong Forecast and Strategic Moves Justify Buy Rating
- Microchip Technology Reports Q4 and Fiscal 2025 Results